-+ 0.00%
-+ 0.00%
-+ 0.00%

Jones Trading Downgrades BioLine Rx to Hold

Benzinga·04/02/2025 11:47:19
Listen to the news
Jones Trading analyst Justin Walsh downgrades BioLine Rx (NASDAQ:BLRX) from Buy to Hold.